M. Ishihara et al., DETECTION OF ANTIBODIES TO BORRELIA SPECIES AMONG PATIENTS WITH CONFIRMED SARCOIDOSIS IN A REGION WHERE LYME-DISEASE IS NONENDEMIC, Graefe's archive for clinical and experimental ophthalmology, 234(12), 1996, pp. 770-773
Background: Lyme disease is a multisystemic disorder caused by the spi
rochete Borrelia burgdorferi, while sarcoidosis is a multisystemic gra
nulomatous disease of unknown etiology. The purpose of this study was
to evaluate the relationship between Lyme disease and sarcoidosis. Met
hods: We examined the seroprevalence of antibody to Borellia species i
n patients with sarcoidosis. We performed the enzyme-linked immunosorb
ent assay, using three Japanese Borrelia species in addition to B. bur
gdorferi, and dotblot analysis using purified Borrelia-specific protei
ns in 38 patients with histopathologically confirmed sarcoidosis and 8
0 healthy controls. Results. Two patients (5.3%) were positive for ant
ibodies to Borrelia species according to one or both assays, and one (
1.2%) healthy control was positive. In both patients it was suspected
that Borrelia infection had developed prior to the development of sarc
oidosis. Conclusion: Borrelia species were thought not to be responsib
le for the development of sarcoidosis in a nonendemic region in Japan.
Since clinical manifestations of Lyme disease share certain similarit
ies with those seen in sarcoidosis, ophthalmologists should be aware o
f the need to differentiate between the two diseases and the need for
prompt treatment in each case.